Publication:
Zoledronic acid for the treatment of thalassemia-induced osteonecrosis.

dc.contributor.authorPat Mahachoklertwattanaen_US
dc.contributor.otherMahidol Universityen_US
dc.date.accessioned2018-08-20T07:12:21Z
dc.date.available2018-08-20T07:12:21Z
dc.date.issued2006-09-01en_US
dc.identifier.citationHaematologica.. Vol.91, No.9 (2006)en_US
dc.identifier.issn15928721en_US
dc.identifier.other2-s2.0-33750591425en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/123456789/23625
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=33750591425&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleZoledronic acid for the treatment of thalassemia-induced osteonecrosis.en_US
dc.typeNoteen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=33750591425&origin=inwarden_US

Files

Collections